We are committed to serving the best interests of our shareholders.

<< Back
3/01/2018

TESARO Announces Participation at Two Investor Conferences

WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:     

  • The Barclays Global Healthcare Conference at the Loews Hotel in Miami, Florida on Wednesday, March 14, 2018.Lonnie Moulder, CEO of TESARO, will participate in an analyst-led moderated Q&A from 2:35 to 3:00 PM ET and in meetings with investors.
     
  • The Morgan Stanley Healthcare Corporate Access Day at the Boston Harbor Hotel in Boston, Massachusetts on Tuesday, March 20, 2018.Tim Pearson, EVP and CFO of TESARO, will participate in meetings with investors.

A live webcast of the presentation at the Barclays conference will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. Archived replays of these webcasts will be available on the Company’s website for 14 days following the conferences.

About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.

For additional information, please contact:   
Jennifer Davis
1.781.325.1116
jdavis@tesarobio.com

Primary Logo

Source: TESARO, Inc.